Cargando…

Two Decades after Mandibuloacral Dysplasia Discovery: Additional Cases and Comprehensive View of Disease Characteristics

Pathogenic variants in the LMNA gene cause a group of heterogeneous genetic disorders, called laminopathies. In particular, homozygous or compound heterozygous variants in LMNA have been associated with “mandibuloacral dysplasia type A” (MADA), an autosomal recessive disorder, characterized by mandi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jéru, Isabelle, Nabil, Amira, El-Makkawy, Gehad, Lascols, Olivier, Vigouroux, Corinne, Abdalla, Ebtesam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535562/ https://www.ncbi.nlm.nih.gov/pubmed/34680903 http://dx.doi.org/10.3390/genes12101508

Ejemplares similares

Hutchinson-Gilford Progeria Versus Mandibuloacral Dysplasia
por: Mehrez, Mennat Allah I, et al.
Publicado: (2014)

Mandibuloacral Dysplasia Caused by LMNA Mutations and Uniparental Disomy
por: Bai, Shaochun, et al.
Publicado: (2014)

Transcatheter Aortic Valve Replacement in a Young Patient With Mandibuloacral Dysplasia
por: Stefanescu Schmidt, Ada C., et al.
Publicado: (2021)

Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment
por: Camozzi, Daria, et al.
Publicado: (2012)

Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology
por: Elouej, Sahar, et al.
Publicado: (2020)

Rapamycin treatment of Mandibuloacral Dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics
por: Cenni, Vittoria, et al.
Publicado: (2014)

Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution
por: Capanni, Cristina, et al.
Publicado: (2012)

Author Correction: Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology
por: Elouej, Sahar, et al.
Publicado: (2020)

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019)

SUN-037 Diagnosis Challenge in Type 4 Familial Partial Lipodystrophic Syndrome
por: Vantyghem, Marie-Christine, et al.
Publicado: (2019)

Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from Southern China
por: Luo, Di-Qing, et al.
Publicado: (2014)

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)

Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease
por: Ceccarini, Giovanni, et al.
Publicado: (2020)

Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
por: Vigouroux, Corinne, et al.
Publicado: (2018)

Mandibuloacral dysplasia in a young Vietnamese girl caused by homozygous missense variant c.1579C>T in the LMNA gene with progeria and severe skin lesions
por: Doanh, Le Huu, et al.
Publicado: (2021)

Hutchinson–Gilford Syndrome (Progeria) with Heterozygous Mutation in the LMNA Gene-ENST00000368300.9 Presenting with Mandibuloacral Dysplasia and Acrogeroid Features—Overlap of Premature Aging Syndromes
por: Muralidharan, Sniya, et al.
Publicado: (2022)

Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines
por: Hitzert, M. M., et al.
Publicado: (2019)

Cutaneous and metabolic defects associated with nuclear abnormalities in a transgenic mouse model expressing R527H lamin A mutation causing mandibuloacral dysplasia type A (MADA) syndrome
por: D’Apice, Maria Rosaria, et al.
Publicado: (2020)

Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes
por: Gautheron, Jérémie, et al.
Publicado: (2022)

Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice
por: Mosbah, Héléna, et al.
Publicado: (2020)

Molecular and Cellular Bases of Lipodystrophy Syndromes
por: Zammouri, Jamila, et al.
Publicado: (2022)

Hypoparathyroidism, deafness and renal dysplasia syndrome caused by a GATA3 splice site mutation leading to the activation of a cryptic splice site
por: Gonçalves, Catarina I., et al.
Publicado: (2023)

Ethnicity and gender trends of UK authors in The British Medical Journal and the Lancet over the past two decades: a comprehensive longitudinal analysis
por: Abdalla, Salwa, et al.
Publicado: (2023)

DNA methylation in cancer: three decades of discovery
por: Feinberg, Andrew
Publicado: (2014)

A decadal view of biodiversity informatics: challenges and priorities
por: Hardisty, Alex, et al.
Publicado: (2013)

Neurokinin B and pre-eclampsia: a decade of discovery
por: Page, Nigel M
Publicado: (2010)

Retrospective on a decade of machine learning for chemical discovery
por: von Lilienfeld, O. Anatole, et al.
Publicado: (2020)

GATA2 deficiency syndrome: A decade of discovery
por: Homan, Claire C., et al.
Publicado: (2021)

Seven Decades of Levothyroxine: A Comprehensive Profile
por: Duntas, Leonidas H.
Publicado: (2019)

The Multifaceted Role of Epoxide Hydrolases in Human Health and Disease
por: Gautheron, Jérémie, et al.
Publicado: (2020)

Discovery problems: a statistical view
por: Cox, David
Publicado: (2011)

Editorial: Endocrine and metabolic diseases – genetic impact and therapies
por: Jéru, Isabelle, et al.
Publicado: (2022)

Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery
por: Copeland, Robert A.
Publicado: (2018)

AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases
por: Wang, Lufei, et al.
Publicado: (2020)

Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
por: Oh, Sangmi, et al.
Publicado: (2021)

Epidemiology and costs of surgical treatment of developmental dysplasia of hip in the Brazilian Public Health System in a decade
por: Souza, Bruno Gonçalves Schröder e, et al.
Publicado: (2021)

Prediction of the requirement of open reduction for developmental dysplasia of the hip
por: Alassaf, Nabil
Publicado: (2017)

EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence
por: Gautheron, Jeremie, et al.
Publicado: (2021)

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

Diverse Views in the Assignment of Credit for Research Discoveries
por: Seeman, Jeffrey I.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dn11e23i5b1hg0al8rv1ovmoiq